Nabil’s nearly 20 year journey with genomics started when he spent eight years at the Broad Institute first managing a team that worked on the completion of the Human Genome Project then transitioning to work on developing and scaling prototype next generation sequencing (NGS) technology to genome center production.
Over the span of his career, Nabil founded an NGS consulting company that provided lab and informatics consulting, pioneered clinical genomics software at GenomeQuest, and was Product Director for Neurology at Quest Diagnostics overseeing their neurology diagnostic testing product portfolio and launching a number of cutting edge products including Quest’s first ever digital diagnostic test. Most recently, Nabil was Sr. Director of Product Management at Sunquest where he managed product and marketing for the Molecular & Genetics product portfolio.
Nabil holds an MBA from Duke University, an MS in Bioinformatics from Brandeis University, and a BS in Biology from Binghamton University.
Cancer has touched us all. I’m honored to be part of a team providing clinicians tools to bring genetics to mainstream medicine to revolutionize cancer diagnosis and treatment."